Botanical species · safety record

Anemone chinensis

The EFSA Compendium of Botanicals holds 7 constituent measurements for Anemone chinensis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Anemone chinensis Bunge

7Constituent measurements

0Safety records

5Cited sources

55Licensed products (Canada)

Also recorded as

Pulsatilla chinensis (Bunge) Regel

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 55 licensed products naming Anemone chinensis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
solid

Source material stated

Radix
Root
Sclerotium

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Beta-peltatin a	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Methoxsalen	Roots and other underground parts	Solvent extraction	—	HPLC with standard detection methods	Resolve DOI
Pentacyclic triterpene saponins	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Pinoresinol	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Saponins	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Saponins	Unspecified	Solvent extraction	—	HPLC-DAD	Resolve DOI
Esculetin	Roots and other underground parts	—	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Mimaki, Y., Kuroda, M., Asano, T., Sashida, Y. Triterpene saponins and lignans from the roots of Pulsatilla chinensis and their cytotoxic activity against HL-60 cells. JOURNAL OF NATURAL PRODUCTS, 1999, vol. 62, no. 9, p. 1279-1283. DOI
Quan, Gui-Hua., Oh, Sei-Ryang., Song, Hyuk-Hwan., Lee, Hyeong-Kyu., Chin, Young-Won. Preparative Isolation of 8-Methoxypsoralen from the Rhizomes of Pulsatilla chinensis using High-speed Counter-current Chromatography. JOURNAL OF THE KOREAN SOCIETY FOR APPLIED BIOLOGICAL CHEMISTRY, 2011, vol. 54, no. 4, p. 623-627. DOI
Xu, Qiong-ming., Shu, Zhan., Zhu, Wei-feng., Liu, Yan-li., Li, Xiao-ran., Yang, Shi-lin. Lupane-Type Triterpenoidal Saponins from Pulsatilla chinensis and Their Anticomplement Activities through the Classical Pathway. PLANTA MEDICA, 2013, vol. 79, no. 6, p. 506-512. DOI
Yang, Lu., Wang, Liang., Yin, Zhong-qiong., Li, Fu-xing., Jia, Ren-yong., Wang, Hui., Liu, Yu. Content determination of esculetin in modified Radix Pulsatillae granule by RP-HPLC.. Zhongshouyi yiyao zazhi, 2014, vol. 33, no. 1, p. 39-43.
Liu, Qiang., Chen, Weichang., Jiao, Yang., Hou, Jianquan., Wu, Qingyu., Liu, Yanli., Qi, Xiaofei. Pulsatilla saponin A, an active molecule from Pulsatilla chinensis, induces cancer cell death and inhibits tumor growth in mouse xenograft models. JOURNAL OF SURGICAL RESEARCH, 2014, vol. 188, no. 2, p. 387-395. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature